ReviewFrontiers in neurology2020

Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1.

Costanza Simoncini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.